Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT06148649 · COMPLETED

Trial details

NCT number: NCT06148649
Sponsor: Dongguan HEC Biopharmaceutical R&D Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-12-10
Primary completion: 2025-02-27
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.